Targeted delivery of peptides, proteins, and genes by receptor-mediated endocytosis

Critical Reviews in Therapeutic Drug Carrier Systems

Volumn 14, Issue 3, 1997, Pages 287-331

  Kato, Yukio ^a   Sugiyama, Yuichi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Drug targeting; Gene; Polypeptide; Protein; Receptor mediated endocytosis

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; ANTISENSE OLIGONUCLEOTIDE; ASIALOGLYCOPROTEIN RECEPTOR; CELL SURFACE RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; FC RECEPTOR; GLYCOPROTEIN P; GROWTH HORMONE; INSULIN RECEPTOR; LOW DENSITY LIPOPROTEIN RECEPTOR; OX 26; PEPTIDE; PROTEIN; PSEUDOMONAS EXOTOXIN; RECEPTOR ANTIBODY; SECRETORY COMPONENT; SOMATOMEDIN B RECEPTOR; SOMATOMEDIN RECEPTOR; TOXIN; TRANSFERRIN RECEPTOR; TRANSFORMING GROWTH FACTOR ALPHA; UNCLASSIFIED DRUG; VITAMIN RECEPTOR;

BINDING KINETICS; CELL MEMBRANE TRANSPORT; COVALENT BOND; DRUG BINDING; DRUG TARGETING; ENDOCYTOSIS; GENE TARGETING; HUMAN; INTRACELLULAR TRANSPORT; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PROTEIN TARGETING; RECEPTOR DOWN REGULATION; REVIEW; SUBCUTANEOUS DRUG ADMINISTRATION; TRANSPORT KINETICS;

EID: 0030806214     PISSN: 07434863     EISSN: None     Source Type: Journal    
DOI: 10.1615/critrevtherdrugcarriersyst.v14.i3.30     Document Type: Review

References (156)

1. Wu, G. Y. and Wu, C. H., Liver-directed gene delivery, Adv. Drug Delivery Rev., 12, 159, 1993.
2. Pardridge, W. M., Recent developments in peptide drug delivery to the brain, Pharmacol. Toxicol., 71, 3, 1992.
3. Strom, T. B., Anderson, P. L., Rubin-Kelley, V. E., Williams, D. P., Kiyokawa, T., and Murphy, J. R., Immunotoxins and cytokine toxin fusion proteins, Ann. NY Acad. Sci., 636, 233, 1991.
4. Wilson, J. M., Grossman, M., Wu, C. H., Chowdhury, N. R., Wu, G. Y., and Chowdhury, J. R., Hepatocyte-directed gene transfer in vivo leads to transient improvement of hypercholesterolemia in low density lipoprotein receptor-deficient rabbits, J. Biol. Chem., 267, 963, 1992.
5. Perales, J. C., Ferkol, T., Beegen, H., Ratnoff, O. D., and Hanson, R. W., Gene transfer in vivo: Sustained expression and regulation of genes introduced into the liver by receptor-targeted uptake, Proc. Natl. Acad. Sci. USA, 91, 4086, 1994.
6. Tepler, I., Schwartz, G., Parker, K., Charette, J., Kadin, M. E., Woodworth, T. G., and Schnipper, L. E., Phase I trial of an interleukin-2 fusion toxin (DAB486IL-2) in hematologic malignancies: Complete response in a patient with Hodgkin's disease refractory to chemotherapy, Cancer, 73, 1276, 1994.
7. Batra, J. K., Jinno, Y., Chaudhary, V. K., Kondo, T., Willingham, M. C., Fitzgerald, D. J., and Pastan, I., Antitumor activity in mice of an immunotoxin made with anti-transferrin receptor and a recombinant form of pseudomonas exotoxin, Proc. Natl. Acad. Sci. USA., 86, 8545, 1989.
8. Takahashi, T., Yamaguchi, T., Kitamura, K., Suzuyama, H., Honda, M., Yokota, T., Kotanagi, H., Takahashi, M., and Hashimoto, Y., Clinical application of monoclonal antibody-drug conjugates for immunotargeting chemotherapy of colorectal carcinoma, Cancer, 61, 881, 1988.
9. Aboud-Pirak, E., Hurwitz, E., Bellot, F., Schlessinger J., and Sela M., Inhibition of human tumor growth in nude mice by a conjugate doxorubicin with monoclonal antibodies to epidermal growth factor receptor, Proc. Natl. Acad. Sci. USA, 86, 3778, 1989.
10. Wu, G. Y. and Wu, C. H., Receptor-mediated gene delivery and expression in vivo, J. Biol. Chem., 263, 14621, 1988.
11. Shapiro, J. T., Leng, M., and Felsenfeld, G., Deoxyribonucleic acid-polylysine complexes. Structure and nucleotide specificity, Biochemistry, 8, 3219, 1969.
12. French, A. R., Sudlow, G. P., Wiley, H. S., and Lauffenburger, D. A., Postendocytic trafficking of epidermal growth factor-receptor complexes is mediated through saturable and specific endosomal interactions, J. Biol. Chem., 269, 15749, 1994.
13. Bomsel, M. and Mostov K., Sorting of plasma membrane proteins in epithelial cells, Curr. Opin. Cell Biol., 3, 647, 1991.
14. Perales, J. C., Ferkol, T., Molas, M., and Hanson, R. W., An evaluation of receptor-mediated gene transfer using synthetic DNA-ligand complexes, Eur. J. Biochem., 226, 255, 1994.
15. Curiel, D. T., Agarwal, S., Wagner, E., and Cotten, M., Adenovirus enhancement of transferrin-polylysine-mediated gene delivery, Proc. Natl. Acad. Sci. USA, 88, 8850, 1991.
16. 131I-labeled follicle-stimulating hormone in mouse sertoli cells and its relevance to other systems., J. Biol. Chem., 264, 13632, 1989.
17. Kato, Y. and Sugiyama, Y., Binding, internalization, degradation, and mitogenic effect of epidermal growth factor in cultured rat hepatocytes, STP Pharm. Sci., 3, 75, 1993.
18. Sugiyama, Y. and Kato, Y., In vitro models of hepatic uptake: Methods to determine kinetic parameters for receptor-mediated hepatic uptake, in Peptide-Based Drug Design: Controlling Transport and Metabolism, Taylor, M. D. and Amidon, G. L., Eds., American Chemical Society, Washington, D.C., 1995, 525.
19. Sugiyama, Y., Kim, D. C., Sato, H., Yanai, S., Satoh, H., Iga, T., and Hanano, M., Receptor-mediated disposition of polypeptides: Kinetic analysis of the transport of epidermal growth factor using in vitro, isolated perfused organs, and in vivo system, J. Control Rel., 13, 157, 1990.
20. Sugiyama, Y., Sato, H., Yanai, S., Kim, D. C., Miyauchi, S., Sawada, Y., Iga, T., and Hanano, M., Receptor-mediated hepatic clearance of peptide hormones, in Topics in Pharmaceutical Sciences 1989, Breimer, D. D., Crommelin, D. J. A., and Midha. K. K., Eds., Amsterdam Medical Press, Noordwijk, 1989, 429.
21. Liu, K., Kato, Y., Narukawa, M., Kim, D. C., Hanano, M., Higuchi, O., Nakamura, T., and Sugiyama, Y., Importance of the liver in plasma clearance of hepatocyte growth factor in rats, Am. J. Physiol., 263, G642, 1992.
22. Liu, K., Kato, Y., Yamazaki, M., Higuchi, O., Nakamura, T., and Sugiyama, Y., Decrease in the hepatic clearance of hepatocyte growth factor in carbon tetrachloride-intoxicated rats, Hepatology, 17, 651, 1993.
23. Liu, K., Kato, Y., Terasaki, T., Nakamura, T., and Sugiyama, Y., Change in hepatic handling of hepatocyte growth factor during liver regeneration in rats, Am. J. Physiol., 269, G745, 1995.
24. Kuwabara, T., Kato, Y., Kobayashi, S., Suzuki, H., and Sugiyama, Y., Non-linear pharmacokinetics of the recombinant granulocyte colony-stimulating factor nartograstim: Species differences among rats, monkeys, and humans, J. Pharmacol. Exp. Ther., 271, 1535, 1994.
25. Kuwabara, T., Uchimura, T., Kobayashi, H., Kobayashi, S., and Sugiyama, Y., Receptor-mediated clearance of G-CSF derivative nartograstim in bone marrow of rats, Am. J. Physiol., 269, E1, 1995.
26. Kuwabara, T., Uchimura, T., Takai, K., Kobayashi, H., Kobayashi, S., and Sugiyama, Y., Saturable uptake of a recombinant human granulocyte colony-stimulating factor derivative, nartograstim, by the bone marrow and spleen of rats in vivo, J. Pharmacol. Exp. Ther., 273, 1114, 1995.
27. Sanyal, G., Marquis-Omer, D., Gress, J. O., Middaugh, C. R., A transforming growth factor-α-Pseudomonas exotoxin hybrid protein undergoes pH-dependent conformational changes conducive to membrane interaction, Biochemistry, 32, 3488, 1993.
28. Mesri, E. A., Kreitman, R. J., Fu, Y., Epstein, S. E., and Pastan, I., Heparin-binding transforming growth factor a-pseudomonas exotoxin A, J. Biol. Chem., 268, 4853, 1993.
29. Trouet, A., Masquelier, M., Baurain, R., and Campeneere, D. D., A covalent linkage between daunorubicin and proteins that is stable in serum and reversible by lysosomal hydrolases, as required for a lysosomotropic drug-carrier conjugate: In vitro and in vivo studies, Proc. Natl. Acad. Sci. USA, 79, 626, 1982.
30. Seymour, L. W., Ulbrich, K., Wedge, S. R., Hume, I. C., Strohalm, J., and Duncan, R., N-(2-hydroxypropyl) methacrylamide copolymers targetted to the hepatocyte galactose-receptor: pharmacokinetics in DBA2 mice, Br. J. Cancer, 63, 859, 1991.
31. Wu, C. H., Wilson, J. M., and Wu, G. Y., Targeting genes: Delivery and persistent expression of a foreign gene driven by mammalian regulatory elements in vivo, J. Biol. Chem., 264, 16985, 1989.
32. Wu, G. Y., Wilson, J. M., Shalaby, F., Grossman, M., Shafritz, D. A., and Wu, C. H., Receptor-mediated gene delivery in vivo. Partial correction of genetic analbuminemia in Nagase rats, J. Biol. Chem., 266, 14338, 1991.
33. Wilson, J. M., Grossman, M., Cabrera, J. A., Wu, C. H., and Wu, G. Y., A novel mechanism for achieving transgene persistence in vivo after somatic gene transfer into hepatocytes, J. Biol. Chem., 267, 11483, 1992.
34. Wagner, E., Cotten, M., Foisner, R., and Birnstiel, M. L., Transferrin-polycation-DNA complexes: the effect of polycations on the structure of the complex and DNA delivery to cells, Proc. Natl. Acad. Sci. USA, 88, 4255, 1991.
35. Ferkol, T., Lindberg, G. L., Chen, J., Perales, J. C., Crawford, D. R., Ratnoff, O. D., and Hanson, R. W., Regulation of the phosphoenolpyruvate carboxykinase/human factor IX gene introduced into the livers of adult rats by receptor-mediated gene transfer, FASEB J., 7, 1081, 1993.
36. Chen, J., Gamou, S., Takayanagi, A., and Shimizu, N., A novel gene delivery system using EGF receptor-mediated endocytosis, FEBS Lett., 338, 167, 1994.
37. Ding, Z. M., Cristiano, R. J., Roth, J. A., Takacs, B., and Kuo, M. T., Malarial circumsporozoite protein is a novel gene delivery vehicle to primary hepatocyte cultures and cultured cells, J. Biol. Chem., 270, 3667, 1995.
38. Yoshikawa, T. and Pardridge, W. M., Biotin delivery to brain with a covalent conjugate of avidin and a monoclonal antibody to the transferrin receptor, J. Pharmacol. Exp. Ther., 263, 897, 1992.
39. Bickel, U., Yamada, S., and Pardridge, W. M., Synthesis and bioactivity of monobiotinylated DALDA: a mu-specific opioid peptide designed for targeted brain delivery, J. Pharmacol Exp. Ther., 268, 791, 1994.
40. Kang, Y. S. and Pardridge, W. M., Use of neutral avidin improves pharmacokinetics and brain delivery of biotin bound to an avidin-monoclonal antibody conjugate, J. Pharmacol. Exp. Ther., 269, 344, 1994.
41. Green, N. M., Avidin, Adv. Protein Chem., 29, 85, 1975.
42. Allen, T. M., Long-circulating (sterically stabilized) liposomes for targeted drug delivery, TiPS, 15, 215, 1994.
43. Nassander, U. K., Steerenberg, P. A., Poppe, H., Storm, G., Poels, L. G., De-Jong, W. H., and Crommelin, D., J., In vivo targeting of OV-TL 3 immunoliposomes to ascitic ovarian carcinoma cells (OVCAR-3) in athymic nude mice, Cancer Res., 52, 646, 1992.
44. Maruyama, K., Takizawa, T., Yuda, T., Kennel, S. J., Huang, L., and Iwatsuru, M., Targetability of novel immunoliposomes modified with amphipathic poly(ethylene glycol)s conjugated at their distal terminals to monoclonal antibodies, Biochim. Biophy. Acta, 1234, 74, 1995.
45. Torchilin, V. P., Klibanov, A. L., Huang, L., O'Donnell, S., Nossiff, N. D., and Khaw, B. A., Targeted accumulation of polyethylene glycol-coated immunoliposomes in infarcted rabbit myocardium, FASEB J., 6, 2716, 1992.
46. Kawasaki, T. and Ashwell, G., Chemical and physical properties of an hepatic membrane protein that specifically binds asialoglycoproteins, J. Biol. Chem., 251, 1296, 1976.
47. Kawasaki, T. and Ashwell, G., Carbohydrate structure of glycopeptides isolated from an hepatic membrane-binding protein specific for asialoglycoproteins, J. Biol. Chem., 251, 5292, 1976.
48. Fujita, T., Nishikawa, M., Tamaki, C., Takakura, Y., Hashida, M., and Sezaki, H., Targeted delivery of human recombinant superoxide dismutase by chemical modification with mono- and polysaccharide derivatives, J. Pharmacol. Exp. Ther., 263, 971, 1992.
49. Schwartz, A. L., Fridovich, S. E., and Lodish, H. F., Kinetics of internalization and recycling of the asialoglycoprotein receptor in a hepatoma cell line, J. Biol. Chem., 257, 4230, 1982.
50. Lee, Y. C., Townsend, R. R., Hardy, M. R., Lonngren, J., Arnarp, J., Haraldsson, M., and Lonn, H., Binding of synthetic oligosaccharides to the hepatic Gal/GalNAc lectin, J. Biol. Chem., 258, 199, 1983.
51. Chiu, M. H., Tamura, T., Wadhwa, M. S., and Rice K. G., In vivo targeting function of N-linked oligosaccharides with terminating galactose and N-acetylgalactosamine residues, J. Biol. Chem. 269, 16195, 1994.
52. Sawamura, T., Kawasato, S., Shiozaki, Y., Sameshima, Y., Nakada, H., and Tashiro, Y., Decrease of a hepatic binding protein specific for asialoglycoproteins with accumulation of serum asialoglycoproteins in galactosamine-treated rats, Gastroenterology, 81, 527, 1981.
53. Burgess, J. B., Baenziger, J. U., and Browin, W. R., Abnormal surface distribution of the human asialoglycoprotein receptorin cirrhosis, Hepatology, 15, 702, 1992.
54. Weitman, S. D., Lark, R. H., Coney, L. R., Fort, D. W., Fransca, V., Zurawski, Jr., V. R., and Kamen, B. A., Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues, Cancer Res., 52, 3396, 1992.
55. McHugh, M. and Cheng, Y., Demonstration of a high affinity folate binder in human cell membranes and its characterization in cultured human KB cells, J. Biol. Chem., 254, 11312, 1979.
56. Campbell, I. G., Jones, T. A., Foulkes, W. D., and Trowsdale, J., Folate-binding protein is a marker for ovarian cancer, Cancer Res., 51, 5329, 1991.
57. Garin-Chesa, P., Campbell, I., Saigo, P. E., Lewis, Jr., L. J., Old, L. J., Retting, W. J., Trophoblast and ovarian cancer antigen LK26, Am. J. Pathol., 142, 557, 1993.
58. Leamon, C. P. and Low, P. S., Cytotoxicity of momordin-folate conjugates in cultured human cells, J. Biol. Chem., 267, 24966, 1992.
59. Leamon, C. P. and Low, P. S., Delivery of macromolecules into living cells: A method that exploits folate receptor endocytosis, Proc. Natl. Acad. Sci. USA, 88, 5572, 1991.
60. Lee, R. J. and Low, P. S., Delivery of liposomes into cultured KB cells via folate receptor-mediated endocytosis. J. Biol. Chem., 269, 3198, 1994.
61. Wang, S., Lee, R. J., Cauchon, G., Gorenstein, D. G., and Low, P. S., Delivery of antisense oligodeoxyribonucleotides against the human epidermal growth factor receptor into cultured KB cells with liposomes conjugated to folate via polyethylene glycol, Proc. Natl. Acad. Sci. U S A, 92, 3318, 1995.
62. Lee, R. J. and Low, P. S., Folate-mediated tumor cell targeting of liposome-entrapped doxorubicin in vitro, Biochim. Biophys. Acta., 1233, 134, 1995.
63. Anderson, R. G. W., Kamen, B. A., Rothberg, K. G., and Lacey, S. W., Potocytosis: Sequestration and transport of small molecules by caveolæ, Science, 255, 410, 1992.
64. Mayor, S., Rothberg, K. G., and Maxfield, F. R., Sequestration of GPI-anchored proteins in caveolæ triggered by cross-linking, Science , 264, 1948, 1994.
65. Anderson, R. G. W., Caveolæ: Where incoming and outgoing messengers meet, Proc. Natl. Acad. Sci. USA, 90, 10909, 1993.
66. Lisanti, M. P., Scherer, P. E., Vidugiriene, J., Tang, Z., Hermanowski-Vosatka, A., Tu, Y., Cook, R. F., and Sargiacomo, M., Characterization of caveolin-rich membrane domains isolated from an endothelial-rich source: Implications for human disease, J. Cell Biol., 126, 111, 1994.
67. Kamen, B. A., Wang, M., Streckfuss, A. J., Peryea, X., and Anderson, R. G. W., Delivery of folates to the cytoplasm of MA104 cells is mediated by a surface membrane receptor that recycles, J. Biol. Chem., 263, 13602, 1988.
68. Spinella, M. J., Brigle, K. E., Sierra, E. E., and Goldman, I. D., Distinguishing between folate receptor-α-mediated transport and reduced folate carrier-mediated transport in L1210 leukemia cells, J. Biol. Chem., 270, 7842, 1995.
69. Ozawa, S., Ueda, M., Ando, N., Shimizu, N., and Abe, O., Prognostic significance of epidermal growth factor receptor in esophageal squamous cell carcinomas, Cancer, 63, 2169, 1989.
70. Maurizi, M., Scambia, G., Panici, P. B., Ferrandina, G., Almadori, G., Paludetti, G., Vincenzo, R. D., Distefano, M., Brinchi, D., Cadoni, G., and Mancuso, S., EGF receptor expression in primary laryngeal cancer: Correlation with clinico-pathological features and prognostic significance, Int. J. Cancer, 52, 862, 1992.
71. Vitols, S., Angelin, B., Ericsson, S., Gahrton, G., Juliusson, G., Masquelier, M., Paul, C., Peterson, C., Rudling, M., Soderberg-Reid, K., and Tidefelt, V., Uptake of low-density lipoproteins by human leukemic cells in vivo: Relation to plasma lipoprotein levels and possible relevance for selective chemotherapy, Proc. Natl. Acad. Sci. USA, 87, 2598, 1990.
72. Jefferies, W. A., Brandon, M. R., Hunt, S. V., Williams, A. F., Gatter, K. C., and Mason, D. Y., Transferrin receptor on endothelium of brain capillaries, Nature, 312, 162, 1984.
73. Pardridge, W. M., Eisenberg, J., and Yang, J., Human blood-brain barrier transferrin receptor, Metabolism, 36, 892, 1987.
74. Pardridge, W. M., Buciak, J. L., and Friden, P. M., Selective transport of an anti-transferrin receptor antibody through the blood-brain barrier in vivo, J. Pharmacol. Exp. Ther., 259, 66, 1991.
75. Friden, P. M., Walus, L. R., Musso, G. F., Taylor, M. A., Malfroy, B., and Starzyk, R. M., Anti-transferrin receptor antibody and antibody-drug conjugates cross the blood-brain barrier, Proc. Natl. Acad. Sci. USA, 88, 4771, 1991.
76. Shin, S. U., Friden, P., Moran, M., Olson, T., Kang, Y. S., and Pardridge, W. M., and Morrison, S. L., Transferrin-antibody fusion proteins are effective in brain targeting, Proc. Natl. Acad. Sci. USA, 92, 2820, 1995.
77. Lestavel-Delattre, S., Martin-Nizard, F., Clavey, V., Testard, P., Favre, G., Doualin, G., Houssaini, H. S., Bard, J. M., Duriez, P., Delbart C., Soula, G., Lesieur, D., Lesieur, I., Cazin, J., Cazin, M., and Fruchart, J., Low-density lipoprotein for delivery of an acrylophenone antineoplastic molecule into malignant cells, Cancer Res., 52, 3629, 1992.
78. Samadi-Baboli, M., Favre, G., Canal, P., and Soula, G., Low-density lipoprotein for cytotoxic drug targeting: Improved activity of elliptinium derivative against B16 melanoma in mice, Br. J. Cancer, 68, 319, 1993.
79. Schouten, D., van der Kooij, M., Muller, J., Pieters, M. N., Bijsterbosch, M. K., and van Berkel, T. J., Development of lipoprotein-like lipid particles for drug targeting: Neo-high density lipoproteins, Mol. Pharmacol., 44, 486, 1993.
80. Pardridge, W. M., Recent advances in blood-brain barrier transport, Ann. Rev. Pharmacol. Toxicol., 28, 25, 1988.
81. Fukuta, M., Okada, H., Iinuma, S., Yanai, S., and Toguchi, H., Insulin fragments as a carrier for peptide delivery across the blood-brain barrier, Pharm. Res., 11, 1681, 1994.
82. Ferkol, T., Kaetzel, C. S., and Davis, P. B., Gene transfer into respiratory epithelial cells by targeting the polymeric immunoglobulin receptor, J. Clin. Invest., 92, 2394, 1993.
83. Rojanasakul, Y., Wang, L. Y., Malanga, C. J., Ma, J. K., and Liaw, J., Targeted gene delivery to alveolar macrophages via Fc receptor-mediated endocytosis, Pharm. Res., 11, 1731, 1994.
84. Ferkol, T., Perales, J. C., Eckman, E., Kaetzel, C. S., Hanson, R. W., and Davis, P. B., Gene transfer into the airway epithelium of animals by targeting the polymeric immunoglobulin receptor, J. Clin. Invest., 95, 493, 1995.
85. Ashwell, G. and Harford, J., Carbohydrate-specific receptors of the liver, Ann. Rev. Biochem., 51, 531, 1982.
86. Taylor, M. E., Leaning, M. S., and Summerfield, J. A., Uptake and processing of glycoproteins by rat hepatic mannose receptor, Am. J. Physiol., 252, E690, 1987.
87. Franssen, E. J., Jansen, R. W., Vaalburg, M., and Meijer, D. K., Hepatic and intrahepatic targeting of an anti-inflammatory agent with human serum albumin and neoglycoproteins as carrier molecules, Biochem. Pharmacol., 45, 1215, 1993.
88. Nishikawa, M., Kamijo, A., Fujita, T., Takakura, Y., Sezaki, H., and Hashida, M., Synthesis and pharmacokinetics of a new liver-specific carrier, glycosylated carboxymethyldextran, and its application to drug targeting, Pharm. Res., 10, 1253, 1993.
89. Freeman, S. M., Whartenby, K. A., Abraham, G. N., and Zwiebel, J. A., Clinical trials in gene therapy, Adv. Drug Deliv. Rev., 12, 169, 1993.
90. Morgan, J. R., Tompkins, R. G., and Yarmush, M. L., Advances in recombinant retroviruses for gene delivery, Adv. Drug Deliv. Rev., 12, 143, 1993.
91. Trapnell, B. C., Adenoviral vectors for gene transfer, Adv. Drug Deliv. Rev., 12, 185, 1993.
92. Chiou, H. C., Tangco, M. V., Levine, S. M., Robertson, D., Kormis, K., Wu, C. H., and Wu, G. Y., Enhanced resistance to nuclease degradation of nucleic acids complexed to asialoglycoprotein-polylysine carriers, Nucleic Acids Res., 22, 5439, 1994.
93. Wu, G. Y. and Wu, H. W., Receptor-mediated in vitro gene transformation by a soluble DNA carrier system, J. Biol. Chem., 262, 4429, 1987.
94. Martinez-Fong, D., Mullersman, J. E., Purchio, A. F., Armendariz-Borunda, J., and Martinez-Hernandez, A., Nonenzymatic glycosylation of poly-L-lysine: A new tool for targeted gene delivery, Hepatology, 20, 1602, 1994.
95. Chowdhury, N. R., Wu, C. H., Wu, G. Y., Yerneni, P. C., Bommineni, V. R., and Chowdhury, J. R., Fate of DNA targeted to the liver by asialoglycoprotein receptor-mediated endocytosis in vivo. Prolonged persistence in cytoplasmic vesicles after partial hepatectomy, J. Biol. Chem., 268, 11265, 1993.
96. Vlassov, V. V., Balakireva, L. A., and Yakubov, L. A., Transport of oligonucleotides across natural and model membranes, Biochim. Biophys. Acta., 1197, 95, 1994.
97. Citro, G., Perrotti, D., Cucco, C., D'Agnano, I., Sacchi, A., Zupi, G., and Calabretta, B., Inhibition of leukemia cell proliferation by receptor-mediated uptake of c-myb antisense oligodeoxynucleotides, Proc. Natl. Acad. Sci. USA., 89, 7031, 1992.
98. Marcello, A., Loregian, A., Cross, A., Marsden, H., Hirst, T. R., and Palu, G., Specific inhibition of herpes virus replication by receptor-mediated entry of an antiviral peptide linked to Escherichia coli enterotoxin B subunit, Proc. Natl. Acad. Sci. USA., 91, 8994, 1994.
99. Ruwart, M., Approaches to modulating liver transport of peptide drugs, in Peptide-Based Drug Design: Controlling Transport and Metabolism, Taylor, M. D. and Amidon, G. L., Eds., American Chemical Society, Washington, D.C., 1995, 249.
100. Lemaire, M., Azria, M., Dannecker, R., Marbach, P., Schweitzer, A., and Maurer, G., Disposition of sandostatin, a new synthetic somatostatin analogue, in rats, Drug Metab. Dispos., 17, 699, 1989.
101. Pastan, I. and FitzGerald, D., Pseudomonas exotoxin: Chimeric toxins, J. Biol. Chem., 264, 15157, 1989.
102. Ogata, M., Chaudhary, V. K., Pastan, I., and FitzGerald, D. J., Processing of Pseudomonas exotoxin by a cellular protease results in the generation of a 37,000-Da toxin fragment that is translocated to the cytosol, J. Biol. Chem., 265, 20678, 1990.
103. Higgins, C. F., ABC transporters: from microorganisms to man, Ann. Rev. Cell Biol., 8, 67, 1992.
104. Fujita, T., Furitsu, H., Nishikawa, M., Takakura, Y., Sezaki, H., and Hashida, M., Therapeutic effects of superoxide dismutase derivatives modified with mono-or polysaccharides on hepatic injury induced by ischemia/reperfusion, Biochem. Biophys. Res. Commun., 189, 191, 1992.
105. Takakura, Y., Masuda, S., Tokuda, H., Nishikawa, M., and Hashida M., Targeted delivery of superoxide dismutase to macrophages via mannose receptor-mediated mechanism, Biochem. Pharmacol., 47, 853-8, 1994.
106. Harrison, J., Shi, X., Wang, L., Ma, J. K., and Rojanasakul, Y., Novel delivery of antioxidant enzyme catalase to alveolar macrophages by Fc receptor-mediated endocytosis, Pharm. Res., 11, 1110, 1994.
107. Pardridge, W. M., Receptor-mediated transcytosis of peptides through the blood-brain barrier, in Peptide Drug Delivery to the Brain, Pardridge, W. M., Ed., Raven Press, New York, 1991, 160.
108. Meijer, D. K. F. and Molema, G., Targeting of drugs to the liver, Semin. Liver Dis., 15, 202, 1995.
109. Jackle, S., Runquist, E. A., Miranda-Brady, S., and Havel, R. J., Trafficking of the epidermal growth factor receptor and transferrin in three hepatocytic endosomal fractions, J. Biol. Chem., 266, 1396, 1991.
110. Dunn, W. A. and Hubbard, A. L., Receptor-mediated endocytosis of epidermal growth factor by hepatocytes in the perfused rat liver: Ligand and receptor dynamics, J. Cell. Biol., 98, 2148, 1984.
111. Reed, D. K., Newton, C., Fraga, M., Glastad, K., Bagheri, A., Harris, S., and Reed, B. C., An analysis of the relationship between the cellular distribution and the rate of turnover for the separate classes of unoccupied, noncovalently occupied, and covalently occupied insulin receptor, J. Biol Chem., 264, 12673, 1989.
112. Oka, J. A. and Weigel, P. H., Recycling of the asialoglycoprotein receptor in isolated rat hepatocytes, J. Biol. Chem., 258, 10253, 1983.
113. Mizuno, K., Higuchi, O., Tajima, H., Yonemasu, T., and Nakamura, T., Cell density-dependent regulation of hepatocyte growth factor receptor on adult rat hepatocytes in primary culture, J. Biochem., 114, 96, 1993.
114. Yanai, S., Sugiyama, Y., Kim, D. C., Iga, T., Fuwa, T., and Hanano, M., Kinetic analysis of receptor-mediated endocytosis of epidermal growth factor by isolated rat hepatocytes, Am. J. Physiol., 260, C457, 1991.
115. Bottaro, D. P., Bonner-Weir, S., and King, G. L., Insulin receptor recycling in vascular endothelial cells, J. Biol. Chem., 264, 5916, 1989.
116. Knauer, D. J., Wiley, H. S., and Cunningham, D. D., Relationship between epidermal growth factor receptor occupancy and mitogenic response, J. Biol. Chem., 259, 5623, 1984.
117. Wiley, H. S. and Cunningham, D. D., A steady-state model for analyzing the cellular binding, internalization, and degradation ofpolypeptide ligands, Cell, 25, 433, 1981.
118. Bajzer, Z., Myers, A. C., and Vuk-Pavlovic, S., Binding, internalization, and intracellular processing of proteins interacting with recycling receptors, J. Biol. Chem., 264, 13623, 1989.
119. Kato, Y., Seita, T., Kuwabara, T., and Sugiyama, Y., Kinetic analysis of receptor-mediated endocytosis (RME) of proteins and peptides: Use of RME as a drug delivery system, J. Controll. Rel., 39, 191, 1996.
120. Deshpande, D., Toledo-Velasquez, D., Wang, L. Y., Malanga, C. J., Ma, J. K., and Rojanasakul, Y., Receptor-mediated peptide delivery in pulmonary epithelial monolayers, Pharm. Res. 11, 1121, 1994.
121. Cotten, M., Langle-Rouault, F., Kirlappos, H., Wagner, E., Mechtler, K., Zenke, M., Beug, H., and Birnstiel, M. L., Transferrin-polycation-mediated introduction of DNA into human leukemic cells: Stimulation by agents that affect the survival of transfected DNA or modulate transferrin receptor levels, Proc. Natl. Acad. Sci. USA, 87, 4033, 1990.
122. Wagner, E., Zatloukal, K., Cotten, M., Kirlappos, H., Mechtler, K., Curiel, D. T., and Birnstiel, M. L., Coupling of adenovirus to transferrin-polylysine/DNA complexes greatly enhances receptor-mediated gene delivery and expression of transfected genes, Proc. Natl. Acad. Sci. USA, 89, 6099, 1992.
123. Cotten, M., Wagner, E., Zatloukal, K., Phillips, S., Curiel, D. T., and Birnstiel, M. L., High-efficiency receptor-mediated delivery of small and large (48 kilobase) gene constructs using the endosome-disruption activity of defective or chemically inactivated adenovirus particles, Proc. Natl. Acad. Sci. USA, 89, 6094, 1992.
124. Johnson, L. K., Vlodavsky, I., Baxter, J. D., and Gospodarowicz, D., Nuclear accumulation of epidermal growth factor in cultured rat pituitary cells, Nature, 287, 340, 1980.
125. Nesbitt, J. E. and Fuller, G. M., Dynamics of interleukin-6 internalization and degradation in rat hepatocytes, J. Biol. Chem., 267, 5739, 1992.
126. Stenseth, K. and Thyberg, J., Monensin and chloroquine inhibit transfer to lysosomes of endocytosed macromolecules in cultured mouse peritoneal macrophages, Eur. J. Cell Biol., 49, 326, 1989.
127. Iwamoto, Y., Roach, E., Bailey, A., Williams, J. A., and Goldfine, I. D., The effect of chloroquine on the binding, intracellular distribution, and action of insulin on isolated mouse pancreatic acini, Diabetes, 32, 1102, 1983.
128. Seth, P., FitzGerald, D., Ginsberg, H., Willingham, M., and Pastan I., Evidence that the penton base of adenovirus is involved in potentiation of toxicity of Pseudomonas exotoxin conjugated to epidermal growth factor, Mol. Cell Biol., 4, 1528, 1984.
129. Seth, P., FitzGerald, D., Willingham, M., and Pastan, I., Role of a low-pH environment in adenovirus enhancement of the toxicity of a Pseudomonas exotoxin-epidermal growth factor conjugate, J. Virol., 51, 650, 1984.
130. Cristiano, R. J., Smith, L. C., Kay, M. A., Brinkley, B. R., and Woo, S. L., Hepatic gene therapy: Efficient gene delivery and expression in primary hepatocytes utilizing a conjugated adenovirus-DNA complex, Proc. Natl. Acad. Sci., USA, 90, 11548, 1993.
131. Michael, S. I., Huang, C. H., Romer, M. U., Wagner, E., Hu, P. C., and Curiel, D.T., Binding-incompetent adenovirus facilitates molecular conjugate-mediated gene transfer by the receptor-mediated endocytosis pathway, J. Biol. Chem., 268, 6866, 1993.
132. Zatloukal, K., Schneeberger, A., Berger, M., Koszik, F., Schmidt, W., Wagner, E., Cotten, M., Buschle, M., Maass, G., Stingl, G., and Birnstiel, M. L., Genetic modification of cells by receptor-mediated adenovirus-augmented gene delivery: A new approach for immunotherapy of cancer, Verh. Dtsch. Ges. Pathol., 78, 171, 1994.
133. Zatloukal, K., Cotten, M., Berger, M., Schmidt, W., Wagner, E., and Birnstiel, M. L., In vivo production of human factor VIII in mice after intrasplenic implantation of primary fibroblasts transfected by receptor-mediated, adenovirus-augmented gene delivery, Proc. Natl. Acad. Sci. USA, 91, 5148, 1994.
134. Gao, L., Wagner, E., Cotten, M., Agarwal, S., Harris, C., Romer, M., Miller, L., Hu, P. C., and Curiel, D., Direct in vivo gene transfer to airway epithelium employing adenovirus-polylysine-DNA complexes, Hum. Gene Ther., 4, 17, 1993.
135. Wagner, E., Plank, C., Zatloukal, K., Cotten, M., and Birnstiel, M. L., Influenza virus hemagglutinin HA-2 N-terminal fusogenic peptides augment gene transfer by transferrin-polylysine-DNA complexes: Toward a synthetic virus-like gene-transfer vehicle, Proc. Natl. Acad. Sci. USA, 89, 7934, 1992.
136. Wiley, D. C. and Skehel, J. J., The structure and function of the hemagglutinin membrane lycoprotein of influenza virus, Ann. Rev. Biochem., 56, 365, 1987.
137. Pai, L. H., Gallo, M. G., FitzGerald, D. J., and Pastan, I., Antitumor activity of a transforming growth factor alpha-Pseudomonas exotoxin fusion protein (TGF-alpha-PE40), Cancer Res., 51, 2808, 1991.
138. Phillips, P. C., Levow, C., Catterall, M., Colvin, O. M., Pastan, I., and Brem, H., Transforming growth factor-alpha-Pseudomonas exotoxin fusion protein (TGF-alpha-PE38) treatment of subcutaneous and intracranial human glioma and medulloblastoma xenografts in athymic mice, Cancer Res., 54, 1008, 1994.
139. Chaudhary, V. K., FitzGerald, D. J., Adhya, S., and Pastan, I., Activity of a recombinant fusion protein between transforming growth factor type alpha and Pseudomonas toxin, Proc. Natl. Acad. Sci. USA., 84, 4538, 1987.
140. Fu, Y. M., Mesri, E. A., Yu, Z. X., Kreitman, R. J., Pastan, I., and Epstein, S. E., Cytotoxic effects of vascular smooth muscle cells of the chimeric toxin, heparin binding TGF alpha-Pseudomonas exotoxin, Cardiovasc. Res., 27, 1691, 1993.
141. Wan, J., Taub, M. E., Shah, D., and Shen, W., Brefeldin A enhances receptor-mediated transcytosis of transferrin in filter-grown Madin-Darby canine kidney cells, J. Biol. Chem., 267, 13446, 1992.
142. Wood, S. A., Park, J. E., and Brown, W. J., Brefeldin A causes a microtubule-mediated fusion of the trans-Golgi network and early eridosomes, Cell, 67, 591, 1991.
143. Lippincott-Schwartz, J., Yuan, L., Tipper, C., Amherdt, M., Orci, L., and Klausner, R. D., Brefeldin A's effects on endosomes, lysosomes, and the TGN suggest a general mechanism for regulating organelle structure and membrane traffic, Cell, 67, 601.
144. Seetharam, S., Chaudhary, V. K., FitzGerald, D., and Pastan, I., Increased cytotoxic activity of Pseudomonas exotoxin and two chimeric toxins ending in KDEL, J. Biol. Chem., 266, 17376, 1991.
145. Maiter, D., Underwood, L. E., Macs, M., and Ketelslegers, J. M., Acute down-regulation of the somatogenic receptors in rat liver by a single injection of growth hormone, Endocrinology, 122, 1291, 1988.
146. Maiter, D., Underwood, L. E., Macs, M., Davenport, M. L., and Ketelslegers, J. M., Different effects of intermittent and continuous growth hormone (GH) administration on serum somatomedin-c/ Insulin-like growth factor I and liver GH receptors in hypophysectomized rats, Endocrinology, 123, 1053, 1988.
147. Yanai, S., Sugiyama, Y., Iga, T., Fuwa, T., and Hanano, M., Kinetic analysis of the downregulation of epidermal growth factor receptors in rats in vivo, Am. J. Physiol., 258, C593, 1990.
148. Sato, H., Sugiyama, Y., Sawada, Y., Iga, T., Sakamoto, S., Fuwa, T., and Hanano, M., Dynamic determination of kinetic parameters for the interaction between polypeptide hormones and cell-surface receptors in the perfused rat liver by the multiple-indicator dilution method, Proc. Natl. Acad. Sci. USA, 85, 8355, 1988.
149. Sato, H., Sugiyama, Y., Sawada, Y., Iga, T., Fuwa, T., and Hanano, M., Internalization of EGF in perfused rat liver is independent of the degree of receptor occupancy, Am. J. Physiol., 258, G682, 1990.
150. Kato, Y., Sato, H., Ichikawa, M., Suzuki, H., Sawada, Y., Hanano, M., Fuwa, T., and Sugiyama, Y., Existence of two pathways for the endocytosis of epidermal growth factor by rat liver: Phenylarsine oxide-sensitive and -insensitive pathways, Proc. Natl. Acad. Sci. USA, 89, 8507, 1992.
151. Sugiyama, Y., Liu, K., Nakamura, T., and Kato, Y., Modelization of tissue transfer of peptide: Hepatic transport of epidermal growth factor (EGF) and hepatocyte growth factor (HGF), in Proceedings of the International Symposium on Blood Binding and Drug Transfer, Tillement, J. P., Eckert, H., Albengres, E., Barre, J., Baumann, P., and Lemaire, M., Eds., Editions Fort et Clair, Paris, 1993, 179.
152. Sugiyama, Y. and Kato, Y., Pharmacokinetic aspects of peptide delivery and targeting: Importance of receptor-mediated endocytosis. Drug Devel. Indust.Pharm., 20, 591, 1994.
153. Mitsuda, S., Nakagawa, T., Osada, T., and Ikai, A., A receptor-mediated antigen delivery and incorporation system. Administration of alpha 2-macroglobulin-cytochrome c conjugate induced high concentrations of antibodies against cytochrome c in mice, Biochem. Biophys. Res. Commun., 191, 1326, 1993.
154. Mukhopadhyay, A., Chaudhuri, G., Arora, S. K., Sehgal, S., and Basu, S. K., Receptor-mediated drug delivery to macrophages in chemotherapy of leishmaniasis, Science, 244, 705, 1989.
155. Molema, G. and Meijer, D. K. F., Targeting of drugs to various blood cell types using (neo-)glycoproteins, antibodies, and other protein carriers, Adv. Drug Delivery Rev., 14, 25, 1994.
156. Pardridge, W. M., Vector-mediated peptide drug delivery to the brain, Adv. Drug Delivery Rev., 15, 109, 1995.